Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-20 Sale |
2021-05-24 4:01 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $77.16 | $1,543,292 | 438,639 (Direct) |
View |
| 2021-04-22 Sale |
2021-04-26 4:03 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
60,000 | $85.39 | $5,123,496 | 728,639 (Direct) |
View |
| 2021-04-16 Sale |
2021-04-20 4:00 pm |
FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Senior VP Clinical Development |
3,275 | $83.3 | $272,809 | 64,800 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-02 6:03 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY See Remarks |
30,000 | $83.81 | $2,514,329 | 118,506 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-16 4:05 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $92.35 | $2,308,772 | 111,896 (Direct) |
View |
| 2021-03-08 Sale |
2021-03-09 4:02 pm |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
25,000 | $81.74 | $2,043,428 | 73,020 (Direct) |
View |
| 2021-02-18 Sale |
2021-02-19 4:07 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $102.01 | $2,040,258 | 408,639 (Direct) |
View |
| 2021-01-21 Sale |
2021-01-22 6:23 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
60,000 | $100.67 | $6,039,968 | 795,080 (Direct) |
View |
| 2021-01-19 Sale |
2021-01-21 7:08 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
35,000 | $114.76 | $4,016,639 | 118,184 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 8:41 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
69,407 | $116.33 | $8,073,772 | 350,562 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 8:40 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
9,484 | $114.95 | $1,090,140 | 77,727 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 8:39 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
9,483 | $114.94 | $1,090,021 | 90,035 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 8:38 pm |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
9,482 | $114.95 | $1,089,911 | 83,609 (Direct) |
View |
| 2021-01-08 Purchase |
2021-01-12 4:16 pm |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
327,485 | $85.5 | $27,999,968 | 13,214,532 (Indirect) |
View |
| 2020-12-17 Sale |
2020-12-18 4:01 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $91.82 | $1,836,352 | 474,815 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-15 4:01 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $97.78 | $2,444,477 | 128,367 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-16 5:12 pm |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
25,000 | $51.83 | $1,295,746 | 93,091 (Direct) |
View |
| 2020-11-12 Sale |
2020-11-16 4:02 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
60,000 | $51.87 | $3,112,424 | 924,815 (Direct) |
View |
| 2020-11-04 Sale |
2020-11-06 4:02 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
70,801 | $50.47 | $3,573,392 | 221,949 (Direct) |
View |
| 2020-10-16 Sale |
2020-10-20 4:01 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
29,199 | $50.25 | $1,467,212 | 185,319 (Direct) |
View |
| 2020-10-01 Sale |
2020-10-02 4:01 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
35,000 | $40.74 | $1,426,065 | 214,518 (Direct) |
View |
| 2020-09-14 Sale |
2020-09-16 4:02 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $36.28 | $907,024 | 153,367 (Direct) |
View |
| 2020-09-14 Sale |
2020-09-16 4:01 pm |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
25,000 | $36.3 | $907,540 | 118,091 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-02 Option Award |
2021-06-04 4:07 pm |
N/A 2031-06-02 |
FATE THERAPEUTICS INC | FATE | Lee Michael Stewart Director |
7,015 | $0 | 7,015 (Direct) |
View |
| 2021-05-20 Exercise |
2021-05-24 4:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $4.835 | 438,639 (Direct) |
View |
| 2021-05-20 Exercise |
2021-05-24 4:01 pm |
N/A 2025-01-04 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $0 | 438,639 (Direct) |
View |
| 2021-04-23 Exercise |
2021-04-26 4:03 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
5,154 | $4.835 | 728,639 (Direct) |
View |
| 2021-04-23 Exercise |
2021-04-26 4:03 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
14,846 | $6.62 | 728,639 (Direct) |
View |
| 2021-04-22 Exercise |
2021-04-26 4:03 pm |
N/A 2027-01-03 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
60,000 | $0 | 728,639 (Direct) |
View |
| 2021-04-22 Exercise |
2021-04-26 4:03 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
40,000 | $2.73 | 728,639 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 6:03 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY See Remarks |
28,149 | $2.9 | 118,506 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 6:03 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY See Remarks |
1,851 | $7.87 | 118,506 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 6:03 pm |
N/A 2026-01-07 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY See Remarks |
30,000 | $0 | 118,506 (Direct) |
View |
Ownership |
2021-04-02 4:32 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Chu Yu-Waye See Remarks |
0 | $0 | 277,426 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-16 4:05 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $2.9 | 111,896 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-16 4:05 pm |
N/A 2026-01-07 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $0 | 111,896 (Direct) |
View |
| 2021-02-18 Exercise |
2021-02-19 4:07 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $6.62 | 408,639 (Direct) |
View |
| 2021-02-18 Exercise |
2021-02-19 4:07 pm |
N/A 2024-01-08 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $0 | 408,639 (Direct) |
View |
| 2021-01-22 Exercise |
2021-01-22 6:23 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $6.62 | 795,080 (Direct) |
View |
| 2021-01-21 Exercise |
2021-01-22 6:23 pm |
N/A 2027-01-03 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
60,000 | $0 | 795,080 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 6:23 pm |
N/A 2031-01-20 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
59,672 | $0 | 795,080 (Direct) |
View |
| 2021-01-21 Exercise |
2021-01-22 6:23 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
40,000 | $2.73 | 795,080 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 6:22 pm |
N/A 2031-01-20 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
24,864 | $0 | 102,591 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 6:21 pm |
N/A 2031-01-20 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
24,864 | $0 | 114,899 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 6:19 pm |
N/A 2031-01-20 |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
19,892 | $0 | 103,501 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 6:18 pm |
N/A 2031-01-20 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
24,864 | $0 | 64,864 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-21 7:08 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
35,000 | $2.9 | 118,184 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-21 7:08 pm |
N/A 2026-01-07 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
35,000 | $0 | 118,184 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 4:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $6.62 | 474,815 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 4:01 pm |
N/A 2024-01-08 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $0 | 474,815 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-15 4:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $2.9 | 128,367 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-15 4:01 pm |
N/A 2026-01-07 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $0 | 128,367 (Direct) |
View |
| 2020-11-13 Exercise |
2020-11-16 4:02 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
9,846 | $7.87 | 924,815 (Direct) |
View |
| 2020-11-13 Exercise |
2020-11-16 4:02 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
10,154 | $6.62 | 924,815 (Direct) |
View |
| 2020-11-12 Exercise |
2020-11-16 4:02 pm |
N/A 2027-01-03 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
60,000 | $0 | 924,815 (Direct) |
View |
| 2020-11-12 Exercise |
2020-11-16 4:02 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
40,000 | $2.73 | 924,815 (Direct) |
View |
| 2020-11-05 Exercise |
2020-11-06 4:02 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
10,000 | $2.9 | 221,949 (Direct) |
View |
| 2020-11-04 Exercise |
2020-11-06 4:02 pm |
N/A 2027-01-03 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
70,801 | $0 | 221,949 (Direct) |
View |
| 2020-11-04 Exercise |
2020-11-06 4:02 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
60,801 | $2.73 | 221,949 (Direct) |
View |
| 2020-10-16 Exercise |
2020-10-20 4:01 pm |
N/A 2027-01-03 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
29,199 | $0 | 185,319 (Direct) |
View |
| 2020-10-16 Exercise |
2020-10-20 4:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
29,199 | $2.73 | 185,319 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-02 4:01 pm |
N/A 2027-01-03 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
35,000 | $0 | 214,518 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-02 4:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
35,000 | $2.73 | 214,518 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 4:02 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
3,076 | $1.69 | 153,367 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 4:02 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
21,924 | $2.9 | 153,367 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 4:02 pm |
N/A 2021-03-11 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $0 | 153,367 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-19 4:12 pm |
N/A 2030-08-17 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |